{"generic":"Benzquinamide Hydrochloride","drugs":["Benzquinamide Hydrochloride","Emete-Con"],"mono":{"0":{"id":"1i5us0","title":"Generic Names","mono":"Benzquinamide Hydrochloride"},"1":{"id":"1i5us1","title":"Dosing and Indications","sub":{"0":{"id":"1i5us1b4","title":"Adult Dosing","mono":"<b>Postoperative nausea and vomiting:<\/b> 50 mg (0.5-1 mg\/kg) IM 15min prior to emergence from anesthesia, may be repeated in 1hr, then every 3-4hrs as needed"},"3":{"id":"1i5us1b7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Postoperative nausea and vomiting<br\/>"}}},"3":{"id":"1i5us3","title":"Contraindications\/Warnings","sub":[{"id":"1i5us3b9","title":"Contraindications","mono":"hypersensitivity to benzquinamide<br\/>"},{"id":"1i5us3b10","title":"Precautions","mono":"<ul><li>do not administer intravenously to patients with cardiovascular disease or with cardiovascular drugs<\/li><li>may mask symptoms of drug overdose<\/li><li>may obscure diagnosis of intestinal obstruction or central nervous system tumors<\/li><li>not recommended for use in children<\/li><\/ul>"},{"id":"1i5us3b11","title":"Pregnancy Category","mono":"Benzquinamide: Fetal risk cannot be ruled out. (TH)<br\/>"},{"id":"1i5us3b12","title":"Breast Feeding","mono":"Benzquinamide: Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"1i5us5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Cardiovascular:<\/b>Abnormal blood pressure<\/li><li><b>Dermatologic:<\/b>Rash<\/li><li><b>Gastrointestinal:<\/b>Loss of appetite, Salivation finding, Xerostomia<\/li><li><b>Neurologic:<\/b>Dystonia, Shivering, Somnolence<\/li><\/ul><b>Serious<\/b><br\/><b>Cardiovascular:<\/b>Cardiac dysrhythmia<br\/>"},"6":{"id":"1i5us6","title":"Drug Name Info","sub":{"0":{"id":"1i5us6b17","title":"US Trade Names","mono":"Emete-Con<br\/>"},"2":{"id":"1i5us6b19","title":"Class","mono":"Antiemetic<br\/>"},"3":{"id":"1i5us6b20","title":"Regulatory Status","mono":"RX<br\/>"}}},"9":{"id":"1i5us9","title":"Administration","mono":"<ul><li><b>General Information<\/b><br\/>not recommended for IV administration<br\/><\/li><li><b>Intramuscular<\/b><br\/>reconstitute 50 mg vial with 2.2 mL Sterile Water for Injection to achieve 50 mg\/2mL<br\/><\/li><\/ul>"},"13":{"id":"1i5us13","title":"Clinical Teaching","mono":"<ul><li>This drug may cause loss of appetite, salivation, xerostomia, dystonia, shivering, or somnolence.<\/li><li>Tell patient to report signs\/symptoms of cardiac dysrhythmias.<\/li><\/ul>"}}}